Healthcare Triangle, Inc. 8-K

What Happened
Healthcare Triangle, Inc. (HCTI) announced on April 7, 2026 that it entered into a Platform Development Agreement with SecureKloud Technologies Limited (SKL) as lead contractor and Blockedge Technologies Inc. as subcontractor, effective March 31, 2026. Under the agreement SKL and Blockedge will design, develop, test and deliver an integrated health advisory and care platform and related tools (including document-management AI tools) to become part of Healthcare Triangle’s commercial offerings. The project term began March 31, 2026 and is expected to finish within 12–15 months, no later than September 30, 2027.

Key Details

• All intellectual property and deliverables created under the Agreement (including enhancements and derivative works) will be owned exclusively by Healthcare Triangle; SKL and Blockedge irrevocably assign those rights and will have no ongoing royalties or ownership.
• Project budget capped at $3.0 million plus a $0.2 million contingency (total $3.2M); any cost overruns beyond $3.2M require prior written approval by Healthcare Triangle.
• The Company previously advanced approximately $3.48M to SKL and $0.345M to Blockedge as of March 31, 2026; advances to Blockedge are transferred to SKL and may be offset against SKL’s invoices. The Company may offset monthly invoices (issued by the fifth working day) against those advances and will not make further payments until advances are fully offset/settled.
• Tools are being developed primarily for deployment in North American and European markets, but Healthcare Triangle may deploy globally without SKL/Blockedge consent.

Why It Matters
This agreement commits Healthcare Triangle to build a proprietary AI-enabled health advisory and care platform while securing full ownership of the resulting intellectual property—important for product control, monetization and competitive positioning. The relatively modest project budget cap ($3.2M max absent approval) and the offset of large prior advances clarify near-term cash flow and vendor payment terms, which investors can factor into expected development timelines and capital use.